← Eichor
Study identifier: NCT07218029 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

A Clinical Study of Sotatercept (MK-7962) in People With Pulmonary Arterial Hypertension (MK-7962-038)

Condition: Pulmonary Arterial Hypertension  ·  Sponsor: Merck Sharp & Dohme LLC

PhasePhase 3
Planned participants815
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

Researchers are looking for more ways to treat PAH. In PAH, the blood vessels in the lungs become thick and narrow, which makes it harder for blood to flow. This causes high blood pressure in the lungs and overworks the heart. PAH can make it hard to breathe and be active. Some standard (usual) treatments for PAH can treat symptoms of PAH but do not stop PAH from getting worse. Sotatercept is a study medicine designed to treat PAH. It is a targeted therapy, which is a treatment that works on certain proteins that play a role in causing PAH. This is a long-term follow-up (LTFU) study. People who took part in certain other studies testing sotatercept for PAH may be able to join this study. The goal of this study is to learn about the long-term safety of sotatercept and if people tolerate it when taken with standard PAH treatment over a longer period of time.

This description comes directly from the study's public registry record.

Talk to the study team

Toll Free Number  ·  1-888-577-8839  ·  Trialsites@msd.com

Always discuss trial participation with your own doctor first.

Locations (129)

Pulmonary Associates, PA ( Site 1008)Phoenix, Arizona, United StatesActive Not Recruiting
Arizona Pulmonary Specialists ( Site 1010)Scottsdale, Arizona, United StatesRecruiting
University of Arizona ( Site 1006)Tucson, Arizona, United StatesRecruiting
University of California San Diego Health ( Site 1002)La Jolla, California, United StatesActive Not Recruiting
UC Irvine Health Medical Center ( Site 1086)Orange, California, United StatesActive Not Recruiting
UC Davis - Medial Center ( Site 1064)Sacramento, California, United StatesRecruiting
UCSF Helen Diller Medical Center at Parnassus Heights ( Site 1019)San Francisco, California, United StatesActive Not Recruiting
Jeffrey S. Sager, MD Medical Corporation ( Site 1060)Santa Barbara, California, United StatesActive Not Recruiting
Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center ( Site 1028)Torrance, California, United StatesActive Not Recruiting
University of Colorado Hospital ( Site 1013)Aurora, Colorado, United StatesActive Not Recruiting
George Washington University Medical Faculty Associates ( Site 1025)Washington D.C., District of Columbia, United StatesRecruiting
Mayo Clinic Jacksonville ( Site 1045)Jacksonville, Florida, United StatesActive Not Recruiting

+ 117 more locations — full list on the registry record.

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07218029